The Dangerous Reasons You Should Never Give Your Baby Tylenol After Vaccines
Conclusion The widely accepted use of acetaminophen pain relievers, such as Tylenol, has been shown in scientific studies to deplete levels of our bodies’ master antioxidant, glutathione. Parents should question the popular notion that dozens of vaccine doses in infancy are safe, and they should certainly research the damaging effects acetaminophen can have on the developing brain. References: http://articles.mercola.com/…vaccine-dosage-for-babies.aspx https://medlineplus.gov/ency/article/003292.htm http://abcnews.go.com/Technology/story?id=97635&page=1 http://abcnews.go.com/Technology/story?id=97635&page=1 https://blogs.scientificamerican.com…why-humans-give-birth-to-helpless-babies/ http://www.thevaccinereaction.org…natures-security-system/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314990/ https://www.nvic.org/Downloads/49-Doses-PosterB.aspx http://www.cbsnews.com/news/study-avoid-tylenol-after-vaccinations/ https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm284563.htm https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261751/ https://www.ncbi.nlm.nih.gov/pubmed/18445737 https://thetruthaboutcancer.com/what-is-glutathione/ VacTruth.com
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
We describe the most highly recommended generic and disease-specific PRO tools in SCD and discuss the challenges of incorporating them in clinical practice. EXPERT OPINION: PRO measures are essential to incorporate into SCD clinical trials either as primary or secondary outcomes. The use of PRO measures in SCD facilitates a patient-centered approach, which is likely to lead to improved outcomes. Significant challenges remain in adapting PRO tools to routine clinical use and in developing countries. PMID: 33034214 [PubMed - as supplied by publisher]
Authors: Musio F Abstract INTRODUCTION: Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. AREAS COVERED: A review of anemia in the context of chronic kidney disease, hematologic malignancies and cancer is presented with focus on the e...
Authors: Bergland OU, Søraas CL, Larstorp ACK, Halvorsen LV, Hjørnholm U, Hoffman P, Høieggen A, Fadl Elmula FEM Abstract PURPOSE: The blood pressure (BP) lowering effect of renal sympathetic denervation (RDN) in treatment-resistant hypertension shows variation amongst the existing randomised studies. The long-term efficacy and safety of RDN require further investigation. For the first time, we report BP changes and safety up to 7 years after RDN, compared to drug adjustment in the randomised Oslo RDN study. MATERIALS AND METHODS: Patients with treatment-resistant hypertension, defined...
Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Currently in fellowship doing bread/butter procedures (MBB, epidurals, PNB, few SCS/PNS trials, etc.) and just interviewed at a private practice spot where they do a lot of procedures that I will have not done any training in prior to graduating (e.g. IT pump, SI fusion, Vertiflex, Kypho, MILD, Discectomy, lots of SCS/PNS trials etc) and significant amount of "OR pain procedures" at a very busy practice seeing 30-40 pts/day - how many of you are commonly performing these procedures and are... private practice concern
Authors: Matti B, Zargar-Shoshtari K Abstract Prostate cancer represents a significant health burden worldwide. The cancer incidence had substantially increased since the introduction of prostate specific antigen (PSA) in cancer screening. This had led to considerable debates among health professionals and epidemiologists, since PSA as a screening tool seemed to be far from perfect. In New Zealand, the controversy was quite prominent in the last three decades, with some advocating the benefits of screening, while others concerned regarding the risk of harms. With the absence of an organised screening programme and ...
CONCLUSION: This study found that childhood cancer survivors in New Zealand had a high prevalence of developmental dental abnormalities and it identified potential risk factors related to their cancer treatment. Inequitable access to oral rehabilitation for this patient group argues for a mechanism for consistent improved access to publicly funded dental care across district health boards in New Zealand. PMID: 33032302 [PubMed - in process]
Authors: Zarrabi A, Mark S PMID: 33032299 [PubMed - in process]
More News: Academies | Acetaminophen | Allergy & Immunology | Antidoxidants | Asthma | Autism | Babies | Babies Heart Conditions | Biology | Blogging | Brain | Brain Cancers | Breastfed | Cancer | Cancer & Oncology | Cancer Vaccines | Cardiology | Chemistry | Child Development | Children | Chronic Pain | Dementia | Genetics | Guinea Health | Health Management | Heart | Heart Disease | Learning | Liver | Lortab | Men | Milk | Neurology | Neuroscience | Nurses | Nursing | Overdose | Pain | Pediatrics | Reflex Sympathetic Dystrophy | Study | Universities & Medical Training | Urology & Nephrology | Vaccines